跳至主要内容
临床试验/NCT02081729
NCT02081729终止不适用

Assessment of VZV-specific ELISPOT Assay for Predicting VZV Infection in Kidney Transplant Recipients (AVE-KT)

Asan Medical Center1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2014年3月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
10
试验地点
1
主要终点
zoster development

研究概览

简要总结

VZV is one of the important opportunistic infection in transplant recipients.Until now, there is no laboratory method to stratify the risk of VZV reactivation after solid organ transplantation. Theoretically, VZV-specific cell-mediate immune response before solid organ transplantation will further categorize the patients into high or low risk of VZV development after solid organ transplantation. The investigators thus evaluate the usefulness of VZV-specific ELISPOT assay in kidney transplant candidates to predict the development of VZV infection after kidney transplantation.

详细描述

We will develop VZV-specific ELISPOT assay, then perform this assay before transplantation. We will evaluate whether this assay will predict zoster reactivation after transplantation.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
16 Years 至 99 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 16 years or more
  • agree with written informed consent
  • WBC count 2000/uL or more

排除标准

  • no exclusion criteria

结局指标

主要结局

zoster development

时间窗: 6 months after transplantation

次要结局

  • mortality(6 months after transplantation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sung-Han Kim

Assocaite Professor

Asan Medical Center

研究点 (1)

Loading locations...

相似试验